Global Prosthetic Heart Valves Market to Exceed $1.3 Billion by 2017, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Prosthetic Heart Valves market. Technological developments, a rapidly rising aging population, and increasing availability and affordability for advanced healthcare in developing nations are all likely to spur the global prosthetic surgical heart valve market to exceed $1.3 billion by 2017. In addition, the introduction of transcatheter valves is likely to expand the global count of aortic valve replacement procedures.

Prosthetic Heart Valves: A Global Strategic Business Report

Prosthetic heart valve market is on the cusp of an important paradigm shift, with the US market set to witness the introduction of percutaneous heart valves also known as transcatheter heart valves. Introduction of the transcatheter aortic valve implantation (TAVI) device has already led to a significant increase in the number of aortic valve procedures in the European market. Currently, the procedure is recommended for high-risk surgical patients with a frail heart or patients who are not advised open-heart surgery. Apart from gaining market share from traditional procedures, the percutaneous heart valve procedure is expected to expand the entire prosthetic heart valve market. Moreover, the average selling price of the new TAVI device is five times that of standard aortic valve, which is likely to further boost value sales of the market.

Apart from transcatheter valves, other technological advancements such as durable tissue heart valves, suture-less valves, and anti-calcification technology, which enhances valve durability through treatment of the prosthetic valve with surface-active compounds, are all expected to propel market penetration of prosthetic heart valves. In addition, favorable demographics, in the form of a rapidly rising aging populace, higher risk of heart valve diseases due to obesity and diabetes, are also likely to propel the prosthetic heart valve market.

Metals, which are being used from the beginning in mechanical heart valves, are gradually being replaced by carbon compounds and sophisticated plastics including polymers. The tissue valve segment is slowly and steadily weaning away market share from the mechanical segment, a trend that is likely to accelerate with the adoption of the transcatheter valves in the US and the rest of world markets.

Tissue valves represent both the larger and faster growing segment, as stated by the new market research report on Prosthetic Heart Valves. The US represents the largest market for prosthetic heart valves. Valvular diseases affect more than 2.5% of the American populace, with the incidence rate particularly high in the 75 years and above category. The tissue valve market represents the larger market. Europe represents the other significant market for prosthetic heart valves. European prosthetic heart valve market is being driven primarily by the introduction of the TAVI procedure in 2007. However, mechanical valves remains the preferred choice for implantation in young people due to their durability factor.

Prosthetic Heart Valve market is a highly consolidated one with the three leading players, Edwards Lifesciences, St. Jude Medical and Medtronic accounting for more than four-fifth of the global market share. Edwards Lifesciences leads the market for tissue valves, while St. Jude Medical leads the market for mechanical valves. Medtronic has moved aggressively in the prosthetic heart valve market, particularly the transcatheter segment, by acquiring three companies during the last two years. Other major players in the market include Abbott Vascular, CryoLife, Inc., On-X Life Technologies, Inc., and the SORIN GROUP.

The research report titled “Prosthetic Heart Valves: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ Million for Prosthetic Heart Valves by two segments: tissue heart valves and mechanical heart valves for major geographic markets including the US, Europe, and the Rest of World.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
E-mail: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website